Find uplifting stories about heroes, innovations, and solutions
6988 results for "cholesterol treatment"
A breakthrough cholesterol pill from Merck just proved it works as well as injections, making life-saving heart disease treatment easier than ever. With heart disease still America's number one killer for a century, this daily pill could help 70% of patients who aren't reaching their cholesterol goals.
A new gene-editing treatment could lower bad cholesterol permanently with just one infusion, eliminating the need for daily medication. Early trial results show a 62% drop in LDL cholesterol that's lasted up to 18 months.
Scientists used gene-editing technology to turn off cholesterol genes in a single treatment, dropping levels by up to 62% without daily pills. Two early trials show the permanent fix could transform heart disease prevention.
A revolutionary gene-editing treatment from Eli Lilly can slash bad cholesterol by up to 62% with just one dose, and the effects last for years. The breakthrough could transform how we prevent heart disease, America's leading killer.
An experimental pill called enlicitide reduced dangerous cholesterol by up to 60% in patients already taking statins, offering millions a simpler alternative to injections. If approved, the daily pill could become a game-changer for the 650,000 Americans who die from heart disease each year.
)
A single gene-editing treatment could replace daily cholesterol pills for millions, after early trials showed one infusion cut dangerous LDL levels by 62% for up to 18 months. Scientists used CRISPR technology to modify how the body naturally clears cholesterol from blood.
Researchers discovered a protein that acts like a master switch for cholesterol, potentially opening doors to new heart disease treatments. The breakthrough could offer an alternative to statins by controlling harmful cholesterol before it even forms.
Scientists tested a one-time gene therapy that lowered cholesterol up to 62% in patients, potentially replacing daily pills and injections with a single treatment. The breakthrough could transform how millions manage heart disease risk.
Researchers at UT Southwestern discovered a protein that controls how much harmful cholesterol the liver releases into the bloodstream. The breakthrough could lead to entirely new treatments for heart disease beyond statins.
A one-time gene-editing treatment lowered dangerous cholesterol levels by 62% in early human trials, offering hope for millions who struggle with heart disease prevention. The therapy produced no serious side effects, marking a major safety milestone.
Researchers discovered how to lower dangerous cholesterol without relying on damaged receptors, offering hope to 1 in 200 adults with a common genetic disorder. The breakthrough uses human liver cells to test compounds that stop cholesterol particles from forming in the first place.
A one-time gene-editing treatment slashed bad cholesterol by 62% in early human trials, offering hope for millions who struggle with heart disease prevention. Eli Lilly's breakthrough therapy showed no serious side effects in the study.
An experimental cholesterol-lowering medication could soon give patients a powerful new weapon against heart disease. The pill offers hope for people who can't tolerate existing treatments or need additional help managing their levels.
Millions struggling with dangerously high cholesterol despite taking statins may soon have a powerful new option that comes in pill form. A groundbreaking trial shows the experimental drug enlicitide slashes bad cholesterol by up to 60 percent, matching the effectiveness of costly shots people currently avoid.
After decades of managing HIV with complex multi-pill regimens, older patients may soon have access to a single daily pill that works just as well. A groundbreaking clinical trial shows the new treatment suppressed the virus in 96% of participants while also improving cholesterol levels.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
A Shanghai neurologist discovered a potential Alzheimer's therapy after his 90-year-old mother improved cognitively following ultrasound treatment for a different condition. His trial now tests high-intensity focused ultrasound as a standalone treatment, a promising departure from mainstream research.
A groundbreaking study will use advanced imaging to personalize cancer treatment, potentially cutting unnecessary therapy while helping more patients access care. The collaboration could transform how doctors decide when prostate cancer patients have received enough treatment.
Showing 20 of 6988